Nucleotide Metabolism Flashcards
Purines and Pyrimidines:
Hypoxanthine is precursor to Adenine
Xanthine is precursor to Guanine
Uracil is aminated to form Cytosine and methylated to form Thymine
Nucleoside and Nucleotide
A nucleoside is a pentose sugar that is attached in a N-glycosidic linkage to the purine or pyrimidine base
In a nucleotide a phosphate is esterified to one of the OH groupss, typically attached to the C-5’ of the nucleoside pentose.
Tide = phosphate
Synthesis of purine nucleotides via the de nova pathway
Linear synthesis pathway:
- PRPP –>* phsophoribosylamine —-> IMP#
* = first committed step in de nova synthesis
= first compound with completed purine ring
Branch point pathways:
IMP -> S-AMP -> AMP
IMP -> XMP -> GMP
Linear Synthesis
(PRPP –> IMP)
- Base is built on ribose
- 10 step energy costly process (5 ATP)
- Gutamine, glycine, aspartate provide nitrogens
- Formate and CO2 provide carbons - note that glycine also provides 2 carbons
Branch Point Synthesis
(IMP-> AMP or IMP-> GMP)
GTP provides free energy for reaction producing AMP
ATP provides free energy for reaciton producing GMP
ATP And GTP are both regulators
PRPP Synthetase
- PRPP synthetase provides substrate (PRPP) for purine de novo synthesis
* D-ribose-5-phosphate gets pyrophase (2 PO4-) - PRPP is also used elsewhere in nucleotide metabolism and in amino acid biosynthesis and so this reaction is not comitted to de novo purine synthesis
Amidophosphoribosyltransferase (ATase)
- ATase catalyzes the displacement of pyrophosphate by the amino group of glutamine.
* This reaction is the first comited (and also rate-limiting) step in the de novo synth. - ATase is subject to allosteric control by PRPP and end products of teh pathway (IMP,AMP, and GMP)
* When PRPP is high, it activates enzyme by monomerization
Synthesis and interconversion of NDPs and NTPs
NMP to NDP done by Adenylate kinase and Guanylate kinase
- AMP + ATP –> 2ADP
- GMP + ATP –> GDP + ADP
- base-specific monophosphate kinases
NDP to NTP done by nucleoside diphosphate kinase
- GDP + ATP -> GTP + ADP
- broad specificity
steady state conditions of adenylate kinase:
100X ATP: 10X ADP: 1X AMP
Purine Nucleotide Metabolism - Regulation
Controlled by relative levels of end products
- End products can regulate PRPP synthetase, ATase, and both branch point pathways (feedback regulation)
- Branch point synthesis can be stimulated by the end product of the opposite branch (cross-regulation)
Degradation and excretion of purine nucleotides
No specific order:
- Dephosphorylation removes phosphate from the pentose sugar
- Deamination removes the amino group from adenine (C-6) and guanine (C-2)
- Phosphoroylsis removes the pentose sugar
AMP -> Inosine -> Hypoxathine -> xanthine -> Uric Acid
GMP -> Guanosine -> Guanine -> xanthine -> Uric Acid
*Adenosine is potent coronary vasodilators (treat heart attack)
Xanthine dehydrogenase/oxidase (XDH/XO)
- XDH and XO convert hypoxanthine and xanthine into uric acid
- encoded by same mRNA
- XDH can be converted to XO under low O2 conditions
- By product of XO is H2O2, so not desirable
Gout - hyperuricemia
Uric acid overproduction or underexcretion
Primary gout (inherited metabolic abnormalities)
- Overexpression of PRPP synthetase
- Deficiency of hypoxanthine guanine phosphoribosyltransferase (HPRT/HGPRT)
- inhibits salvage pathway to turn Guanine -> GMP or Hypoxanthine -> AMP
- Defects in a family of renal urate transport porteins (80% of cases)
Secondary gout (acquired condition)
- Drug intake or unusual dietary habits
- meats contain a lot of nucleotides
Treatment of Gout
Use of Allopurinol that is a competitive inhibitior:
- XDH converts Allopurinol to Alloxanthine (not Xanthine)
- With less XDH available, less xanthine -> Urate production
- Can also get into salvage pathway and turn into AMP/GMP and inhibit ATase by feedback mechanism
Xanthinuria
Deficiency of Xanthine Dehydrogenase (XDH)
- reverse disorder as Gout
- You see increased levels of Guanine, Hypoxanthine and Xanthine
- No treatments - just limiting nucleotide ingestion to reduce levels
*
Immunodeficiency diseases
- A deficiency of adenosine deaminase (ADA) (removes amino group) –> T-cell and B-cell dysfunction (bubble boy)
- A deficiency of purine nucleoside phosphorylase (PNP) (removes pentose sugar) –> impairmen of T-cell function
Both of these diseases lead to 50-100 fold increased dATP or GTP levels in lymphocytes leading to inhibition of Ribonucleotide reductase (DNA synthesis, cell division)